Revenue

Ractigen's RAG-01 advances with NMPA approval, using RNA activation to fight bladder cancer by targeting a previously 'undruggable' gene.

A new drug shows unprecedented activity against all common cold viruses, a major breakthrough for millions suffering from chronic lung diseases.

The UNCF New England Gala shattered fundraising records, raising $800,000 to support HBCU students and honor leaders in educational equity.

The equipment dealer exceeded its inventory reduction goals but faces a net loss and a grim forecast amid a broader agricultural market slump.

Quebec’s new budget maintains support for its vital life sciences sector, but industry leaders warn new tax rules could hinder innovation for small firms.

An Orlando summit reveals how nature-powered solutions, from carbon-negative cement to ecosystem revival, are shaping Florida's resilient future.

A new report reveals how smarter energy use could slash US power bills by tapping into the grid's hidden capacity, with tech giants like Google leading the push.

As its new obesity drug enters a key trial, Biohaven bets on a novel approach: reducing fat while preserving precious muscle mass. Can it redefine weight loss?

Net Lease Office Properties rewards shareholders with a $3.30 special dividend, funded by property sales, amid a challenging office real estate market.

DeepLase Technologies secures seed funding to scale its advanced laser and fiber optic platforms, signaling a new era for India's deep-tech ecosystem.

For women considering surrogacy, the journey often begins with one talk. As the industry grows, agencies are focusing on supporting partners from the start.

The private equity firm partners with Imperial College and extends its Columbia program, aiming to turn sustainability into a core driver of financial value.

A new $7 million deal will use a digital marketplace to deliver 16 million doses of a life-saving antibiotic to children in Burkina Faso. But can it work?

China's MRO giant ZKH Group returns to profitability, fueled by a surge in customers, AI automation, and an aggressive international expansion strategy.

As anime fans demand immersive experiences over merchandise, one company is building a global network of permanent cultural arenas, transforming fandom into tourism.

Belief BioMed's single-dose treatment for hemophilia B, BBM-H901, is now approved in Macao, offering a new horizon for patients beyond frequent injections.

A new report reveals a major shift to AI in safety and sustainability, with firms favoring human-led “co-pilot” models to reduce risk and admin.

After a 43-year wait, Singapore football is reborn. The Lions' historic qualification for the Asian Cup sparks a national celebration and a new era.

Lassila & Tikanoja charts a stable future with a long-term CEO succession plan, following a major strategic pivot to a pure-play circular economy company.

New analysis shows a summer of sporting glory in 2026 could see Brits open their wallets, injecting up to £400 million into the UK economy.